ForewordInformation about a real patient is presented in stages (boldface type) to expert clinicians (Drs Mauri and Dr MacRae), who respond to the information, sharing their reasoning with the reader (regular type). A discussion by the authors follows. P atient presentation: A 52-year-old woman with a medical history of an acute coronary syndrome (ACS) managed with percutaneous coronary intervention (PCI) and scleroderma presented to outpatient cardiology clinic with chest discomfort. She was in her usual state of health until 1 week before presentation, when she developed fatigue and malaise that persisted throughout the week. On the evening before presentation, she awoke with substernal chest pressure that worsened over the next several hours and prevented her from falling back asleep. She presented to her primary cardiologist the following morning with ongoing chest discomfort.Her medical history was notable for a prior circumflex PCI, diffuse cutaneous systemic sclerosis, mononeuritis multiplex, thrombocytopenia, hypertension, hyperlipidemia, hypothyroidism, and gastroesophageal reflux disease. Her PCI occurred 1 year earlier, when she presented with atypical chest pain in the setting of a scleroderma flare and was found to have lateral ST depressions on her ECG and an elevated troponin T level of 0.12 ng/mL. Coronary angiography was performed and revealed 99% occlusion of the left circumflex artery (LCx; Figure 1). The lesion was successfully treated with a everolimus-eluting stent.Her scleroderma was first diagnosed at 29 years of age, when she presented with Raynaud syndrome, sclerodactyly, telangiectasias, and esophagitis and was found to have a positive anticentromere antibody, leading to a diagnosis of limited cutaneous systemic sclerosis. At 34 years of age, she developed widespread skin thickening and subcutaneous calcinoses, leading to a subsequent diagnosis of diffuse cutaneous systemic sclerosis. At 42 years of age, she developed multiple mononeuropathies with electromyographic evidence of mononeuritis multiplex, for which she was treated with a limited course of cyclophosphamide and prednisone with subsequent clinical improvement.Her thrombocytopenia was chronic and without a clear origin. Prior workup revealed positive anti-cardiolipin IgM and anti-β2-glycoprotein 1 antibodies that were thought to be nonspecific. She had no prior thromboembolic events.Her home medications included aspirin 81 mg daily, clopidogrel 75 mg daily, lisinopril 40 mg daily, levothyroxine 50 μg daily, and pantoprazole 40 mg daily. Her scleroderma and mononeuritis multiplex flares were managed with intermittent mycophenolate mofetil and prednisone, which last occurred ≈6 months before presentation. She was married and worked as a nurse educator. She rarely consumed alcohol and had never used tobacco products or illicit substances. Her mother suffered a myocardial infarction in her 50s and later died of heart failure. Her father died at a young age in a motor vehicle accident.On presentation to her cardiologist's office, s...